FRI0169 Influence of Body Mass Index (BMI) on Serum Levels of Infliximab in Patients with Rheumatoid Arthritis (RA)

BackgroundLoss of response of TNFα inhibitors (TNFi) over time resulting in discontinuing of this therapy is a major issue in RA, but underlying reasons for this remains unknown. A few studies suggest the influence of BMI on serum levels of subcutaneous TNFi. However, there is no available data on t...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of the rheumatic diseases 2016-06, Vol.75 (Suppl 2), p.490-491
Hauptverfasser:	Villalba Yllan, A., Navarro Compan, M.V., Plasencia Rodriguez, C., Peiteado Lopez, D., Bonilla Hernan, G., Nuño Nuño, L., Pascual-Salcedo, D., Olariaga, E., Balsa Criado, A., Martin Mola, E.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!